Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 13 08 2018
accepted: 11 06 2019
revised: 18 05 2019
pubmed: 23 6 2019
medline: 26 2 2020
entrez: 23 6 2019
Statut: ppublish

Résumé

Subjective cognitive decline (SCD) can represent a preclinical stage of Alzheimer's disease. Diffusion tensor imaging (DTI) could aid an early diagnosis, yet only few monocentric DTI studies in SCD have been conducted, reporting heterogeneous results. We investigated microstructural changes in SCD in a larger, multicentric cohort. 271 participants with SCD, mild cognitive impairment (MCI) or Alzheimer's dementia (AD) and healthy controls (CON) were included, recruited prospectively at nine centers of the observational DELCODE study. DTI was acquired using identical protocols. Using voxel-based analyses, we investigated fractional anisotropy (FA), mean diffusivity (MD) and mode (MO) in the white matter (WM). Discrimination accuracy was determined by cross-validated elastic-net penalized regression. Center effects were explored using variance analyses. MO and FA were lower in SCD compared to CON in several anterior and posterior WM regions, including the anterior corona radiata, superior and inferior longitudinal fasciculus, cingulum and splenium of the corpus callosum (p < 0.01, uncorrected). MD was higher in the superior and inferior longitudinal fasciculus, cingulum and superior corona radiata (p < 0.01, uncorrected). The cross-validated accuracy for discriminating SCD from CON was 67% (p < 0.01). As expected, the AD and MCI groups had higher MD and lower FA and MO in extensive regions, including the corpus callosum and temporal brain regions. Within these regions, center accounted for 3-15% of the variance. DTI revealed subtle WM alterations in SCD that were intermediate between those in MCI and CON and may be useful to detect individuals with an increased risk for AD in clinical studies.

Identifiants

pubmed: 31227891
doi: 10.1007/s00415-019-09429-3
pii: 10.1007/s00415-019-09429-3
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2465-2474

Références

Neuroimage. 2008 Apr 1;40(2):570-582
pubmed: 18255316
J Alzheimers Dis. 2014;41(1):69-83
pubmed: 24577476
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Alzheimers Dement. 2014 Nov;10(6):844-52
pubmed: 24798886
J Neuroimaging. 2015 Sep-Oct;25(5):738-47
pubmed: 25644739
Front Neurosci. 2013 Mar 12;7:31
pubmed: 23486659
J Neurosci. 2013 Jan 30;33(5):2147-55
pubmed: 23365250
Magn Reson Med. 2006 Jan;55(1):136-46
pubmed: 16342267
J Alzheimers Dis. 2010;19(4):1273-82
pubmed: 20308792
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Neuroimage. 2011 Apr 1;55(3):880-90
pubmed: 21182970
J Alzheimers Dis. 2010;22(2):507-22
pubmed: 20847446
Quant Imaging Med Surg. 2012 Dec;2(4):254-65
pubmed: 23289085
Alzheimers Dement. 2015 Feb;11(2):111-25
pubmed: 25267715
Neuroimage. 2010 Jul 1;51(3):943-51
pubmed: 20211265
Neuroimage. 2017 Jan;144(Pt B):305-308
pubmed: 27046114
Neurobiol Aging. 2007 Mar;28(3):398-403
pubmed: 16529847
J Alzheimers Dis. 2012;31 Suppl 3:S33-47
pubmed: 22992380
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S171-91
pubmed: 26402088
Psychiatry Res. 2011 Dec 30;194(3):363-371
pubmed: 22078796
Biochim Biophys Acta. 2012 Mar;1822(3):423-30
pubmed: 21867750
Int Psychogeriatr. 2017 May;29(5):785-792
pubmed: 28067183
J Int Neuropsychol Soc. 2010 Jan;16(1):58-69
pubmed: 19835655
PLoS One. 2017 Mar 14;12(3):e0173982
pubmed: 28291839
Ann N Y Acad Sci. 2005 Dec;1064:37-49
pubmed: 16394146
Oncotarget. 2016 Aug 23;7(34):54405-54414
pubmed: 27384675
J Alzheimers Dis. 2012;29(2):405-29
pubmed: 22330833
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
Neuropsychol Rev. 2003 Jun;13(2):79-92
pubmed: 12887040
J Korean Med Sci. 2015 Nov;30(11):1652-8
pubmed: 26539011
PLoS One. 2013 May 31;8(5):e64925
pubmed: 23741425
Alzheimers Dement. 2015 Mar;11(3):321-30
pubmed: 25217294
Nat Protoc. 2015 Feb;10(2):293-304
pubmed: 25591011
J Alzheimers Dis. 2013;33(3):723-36
pubmed: 23186987
PLoS One. 2014 Aug 05;9(8):e104007
pubmed: 25093415
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Neurobiol Aging. 2011 Apr;32(4):581-9
pubmed: 19428143
Alzheimers Res Ther. 2018 Feb 07;10(1):15
pubmed: 29415768
Alzheimers Dement. 2012 Oct;8(5 Suppl):S112-21
pubmed: 23021621
Dement Geriatr Cogn Disord. 2004;18(1):101-8
pubmed: 15087585

Auteurs

Katharina Brueggen (K)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany. katharina.brueggen@dzne.de.

Martin Dyrba (M)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.

Arturo Cardenas-Blanco (A)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Anja Schneider (A)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Klaus Fliessbach (K)

Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Katharina Buerger (K)

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Daniel Janowitz (D)

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.

Oliver Peters (O)

Institute of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.

Felix Menne (F)

Institute of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Josef Priller (J)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.

Eike Spruth (E)

Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.

Jens Wiltfang (J)

Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Göttingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.

Ruth Vukovich (R)

Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Göttingen, Germany.

Christoph Laske (C)

Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

Martina Buchmann (M)

Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

Michael Wagner (M)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Sandra Röske (S)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Annika Spottke (A)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Neurology, University of Bonn, Bonn, Germany.

Janna Rudolph (J)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Coraline D Metzger (CD)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-Von-Guericke University, Magdeburg, Germany.
Department of Psychiatry and Psychotherapy, Otto-Von-Guericke University, Magdeburg, Germany.

Ingo Kilimann (I)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Laura Dobisch (L)

Institute of Cognitive Neurology and Dementia Research (IKND), Otto-Von-Guericke University, Magdeburg, Germany.

Emrah Düzel (E)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-Von-Guericke University, Magdeburg, Germany.

Frank Jessen (F)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.

Stefan J Teipel (SJ)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH